Federal and Regulatory Outreach
Response to CMS Request for Information on Prior Authorization
March 8, 2022
Medicare Advantage Prior Authorization Regulatory
Response to Advance Notice for Medicare Advantage Plan Year 2023
March 8, 2022
Medicare Advantage Prior Authorization Regulatory
AMRPA’s Comments to the National Quality Forum on an IRF QRP Measure Under Consideration
January 26, 2022
IRF QRP
AMRPA Comments on Medicare Payment Advisory Commission (MedPAC)’s FY 2023 IRF Payment Update Recommendation
January 11, 2022
MedPAC
AMRPA Joint Letter to HHS Sec. Becerra on LTACHs and IRFs
January 5, 2022
COVID-19 Medicare Advantage Prior Authorization Regulatory
AMRPA Statement on Senate Reintroduction of Improving Seniors’ Timely Access to Care Act
October 21, 2021
Legislative Medicare Advantage Prior Authorization
AMRPA’s Response to US News and World Report’s Rehabilitation Hospital Ranking Methodology for 2022 and 2023
October 12, 2021
Rehab Rankings
AMRPA Response to Second IRF Review Choice Demo Notice
October 8, 2021
Regulatory Review Choice Demonstration
AMRPA Response to CY 2022 Outpatient Prospective Payment System Proposed Rule and Price Transparency Provisions
September 17, 2021
Outpatient PPS Price Transparency Regulatory
Joint Stakeholder Response to RTI re: Unified Post-Acute Care Technical Expert Panel
September 14, 2021
Unified PAC Payment
AMRPA Comments on 2022 Physician Fee Schedule Proposed Rule
September 13, 2021
Physician Fee Schedule Regulatory Telehealth
Report: Medicare Advantage Prior Authorization